| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |